Navigation Links
Structured Diabetes Management can Significantly Improve Overall Glycemic Control and Reduce HbA1c Values in Non-insulin Treated Type 2 Diabetes

ools that enable tangible improvements in the health, quality of life and survival of patients. In 2009, Roche had over 80'000 employees worldwide and invested almost 10 billion Swiss francs in R&D. The Group posted sales of 49.1 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan.

For more information:

About Roche Diabetes CareRoche Diabetes Care is a pioneer in the development of blood glucose monitoring systems and a global leader for diabetes management systems and services. For more than 35 years, the Accu-Chek brand has been dedicated to enable people with diabetes to live life as normal and active as possible as well as to empower healthcare professionals manage their patients' condition in an optimal way. Today, the Accu-Chek portfolio offers people with diabetes and healthcare professionals innovative products and impactful solutions for convenient, efficient and effective diabetes management spanning from blood glucose monitoring through information management to insulin delivery. The Accu-Chek brand encompasses blood glucose meters, insulin delivery systems, lancing devices, data management systems and education programs – leading to an improved medical outcome.

For more information please visit

For more information please contactRoche Diabetes Care

Ute Volkmann

Roche Diagnostics GmbH

Roche Diabetes Care

Todd Siesky

Roche DiagnosticsPhone: +49 621 759 9561

Phone: +1 317 521 3966E-Mail:

E-Mail: All trademarks used or mentioned in this release are legally protected.

(1) Polonsky WH, Fisher L, Shikman CH, Hinnen

SOURCE Roche Diabetes Care
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Federal grant invests in nanostructured super materials
2. Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD
3. Roche Diabetes Care Forms Human Blue Circle, Supports Viral Video for World Diabetes Day
4. Taking Control of Diabetes: Support World Diabetes Day (14th November 2010)
5. Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
6. The World Market for Diabetes Treatments Now Available at ReportsandReports
7. Spherix Announces Statistically Significant Results in Phase 3 Study With D-tagatose in Type 2 Diabetes
8. 52-Week Phase 3 Study Found Investigational Drug Dapagliflozin Plus Metformin Similar to Glipizide Plus Metformin in Improving Glycosylated Hemoglobin (HbA1c) in Adults with Type 2 Diabetes Mellitus
9. Beta-Pro Donates Human Islet Cells to Diabetes Researcher
10. Boehringer Ingelheim Presents New Phase III Data Evaluating Linagliptin in People with Type 2 Diabetes
11. Roche Diabetes Care and ICW Announce Technology Partnership
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015 /PRNewswire/ - RepliCel Life Sciences Inc. ... company focused on the development of autologous cell therapies, today ... partnering meetings taking place in the month of October: ... Partnering Forum RepliCel will be presenting at the ... on the Mesa to be held October 7-9 in ...
(Date:10/8/2015)... ... October 08, 2015 , ... Talon Innovations, a provider of ... other technology-driven industries, announces that it is one of three finalists for the Minnesota ... On Thursday, September 25 Talon Innovations was recognized as a nominee for this ...
(Date:10/7/2015)... , October 8, 2015 ... Medical biotechnology accounts for largest bioinformatics ... bioinformatics in drug discovery and development process ... . --> ... On the basis of applications, the bioinformatics ...
(Date:10/7/2015)... Worth, Texas (PRWEB) , ... October 07, 2015 ... ... Cell Institute ( ) will present a public educational seminar on the ... on Saturday, October 10th from 1:00 pm – 3:00 pm at the Hilton ...
Breaking Biology Technology:
... Private Life Science Companies from ... Southern California, ... life science community, is proud to announce that its,second annual BIOCOM ... from Oct. 31-Nov. 2, 2007. Featuring almost 60 innovative public ...
... ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... commercializing proprietary product candidates for the treatment,of ... Evan M. Levine,ADVENTRX,s chief executive officer, is ... Annual Growth Conference on Wednesday,September 19th, 2007 ...
... Agreement, COPENHAGEN, September 13 Genmab A/S ... exchange agreement with,Medarex, Inc. Under the terms of ... which targets IL-8, and Medarex will,receive full rights ... will release to each other all previously held ...
Cached Biology Technology:
(Date:10/6/2015)... LAKE CITY , Oct. 6, 2015 ... company, announced today that it has signed a contract ... monitoring services across the full range of sentences under ... Group,s President of the Americas. "This contract with the ... region of the US and advances our position as ...
(Date:10/2/2015)... 02 2015 ... "Enforcing the Law Using Biometrics" report to ... announced the addition of the "Enforcing the ... --> Research and Markets ( ... "Enforcing the Law Using Biometrics" report to ...
(Date:9/30/2015)... Sept. 30, 2015  The U.S. Court of Appeals ... key ruling in favor of Crossmatch ™, affirming ... scanner company Suprema and its U.S. partner Mentalix violated ... trade provision that declares it unlawful to engage in ... two of Crossmatch,s patents, the 5,900,993 patent and the ...
Breaking Biology News(10 mins):
... successfully aiding in the replacement of narrowed, calcified ... open-chest surgery. According to a study reported at ... for Cardiovascular Angiography and Interventions (SCAI), May 9?2, ... with the CoreValve Revalving System (CoreValve, Irvine, CA) ...
... aimed at preventing cervical cancer is nearly 100 percent effective ... for most cases of cervical cancer. Results of a nationwide ... 9 issue of the New England Journal of Medicine. , ... deaths in women worldwide, resulting in nearly half a million ...
... at UNIVET, a spin-off of the Universitat Autònoma de ... Petcare, have developed an artificial cellular model which faithfully ... allow, therefore, the carrying out of various lines of ... need to use live animals. , The basic structure ...
Cached Biology News:
Purified anti-Fanconi anemia D2-Phosphorylated (Ser222)...
... Explorer processes up to 48 lanes, 24 ... input can be from either slab gel ... primer chemistries. The detection parameters in Explorer ... analyst consistency. We have built Explorer ...
... Quality ISO 9001:2000 Certified ... All Precedures Validated, SOP's Training ... Process for All Procedures GLP Documentation Upon ... one stop shopping point for all your ...
Biology Products: